ZBTB16
Summary: This gene is a member of the Krueppel C2H2-type zinc-finger protein family and encodes a zinc finger transcription factor that contains nine Kruppel-type zinc finger domains at the carboxyl terminus. This protein is located in the nucleus, is involved in cell cycle progression, and interacts with a histone deacetylase. Specific instances of aberrant gene rearrangement at this locus have been associated with acute promyelocytic leukemia (APL). Alternate transcriptional splice variants have been characterized. [provided by RefSeq, Jul 2008].
Name | OMIM ID | Ensembl ID | HGNC ID | PHARMGKB ID | Map Location |
---|---|---|---|---|---|
zinc finger and BTB domain containing 16 | MIM:176797 | Ensembl:ENSG00000109906 | HGNC:HGNC:12930 | PA37517 | 11q23.2 |
GO terms in ZBTB16
Term Type | Evidence Type | GO Term ID | GO Des. |
---|---|---|---|
BP | IDA | GO:0000122 | negative regulation of transcription by RNA polymerase II |
BP | ISS | GO:0001823 | mesonephros development |
BP | IEA | GO:0006351 | transcription, DNA-templated |
BP | NAS | GO:0006915 | apoptotic process |
BP | ISS | GO:0007417 | central nervous system development |
BP | IEA | GO:0008285 | negative regulation of cell proliferation |
BP | IEA | GO:0009880 | embryonic pattern specification |
BP | IEA | GO:0009952 | anterior/posterior pattern specification |
BP | IEA | GO:0016567 | protein ubiquitination |
BP | IDA | GO:0030097 | hemopoiesis |
BP | TAS | GO:0030097 | hemopoiesis |
BP | TAS | GO:0030099 | myeloid cell differentiation |
BP | IMP | GO:0032332 | positive regulation of chondrocyte differentiation |
BP | IEA | GO:0034504 | protein localization to nucleus |
BP | IEA | GO:0035116 | embryonic hindlimb morphogenesis |
BP | IEA | GO:0035136 | forelimb morphogenesis |
BP | IEA | GO:0042733 | embryonic digit morphogenesis |
BP | IEA | GO:0043065 | positive regulation of apoptotic process |
BP | TAS | GO:0043687 | post-translational protein modification |
BP | IMP | GO:0045600 | positive regulation of fat cell differentiation |
BP | ISS | GO:0045638 | negative regulation of myeloid cell differentiation |
BP | IDA | GO:0045778 | positive regulation of ossification |
BP | IBA | GO:0045892 | negative regulation of transcription, DNA-templated |
BP | IDA | GO:0045892 | negative regulation of transcription, DNA-templated |
BP | NAS | GO:0045892 | negative regulation of transcription, DNA-templated |
BP | IBA | GO:0045893 | positive regulation of transcription, DNA-templated |
BP | IDA | GO:0045893 | positive regulation of transcription, DNA-templated |
BP | IBA | GO:0045944 | positive regulation of transcription by RNA polymerase II |
BP | IEA | GO:0048133 | male germ-line stem cell asymmetric division |
BP | IBA | GO:0048856 | anatomical structure development |
BP | IEA | GO:0051138 | positive regulation of NK T cell differentiation |
BP | IDA | GO:0051216 | cartilage development |
BP | IDA | GO:0061036 | positive regulation of cartilage development |
CC | IBA | GO:0005634 | nucleus |
CC | IDA | GO:0005634 | nucleus |
CC | IBA | GO:0005654 | nucleoplasm |
CC | TAS | GO:0005829 | cytosol |
CC | IEA | GO:0005886 | plasma membrane |
CC | IDA | GO:0016604 | nuclear body |
CC | IDA | GO:0016605 | PML body |
CC | IDA | GO:0016607 | nuclear speck |
CC | IDA | GO:0017053 | transcriptional repressor complex |
CC | IMP | GO:0032991 | protein-containing complex |
MF | IDA | GO:0000980 | RNA polymerase II distal enhancer sequence-specific DNA binding |
MF | ISA | GO:0000981 | RNA polymerase II transcription factor activity, sequence-specific DNA binding |
MF | IDA | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding |
MF | IDA | GO:0003677 | DNA binding |
MF | NAS | GO:0003677 | DNA binding |
MF | IBA | GO:0003700 | DNA-binding transcription factor activity |
MF | IPI | GO:0005515 | protein binding |
MF | IEA | GO:0008022 | protein C-terminus binding |
MF | IEA | GO:0019904 | protein domain specific binding |
MF | IPI | GO:0042802 | identical protein binding |
MF | IDA | GO:0042803 | protein homodimerization activity |
MF | IBA | GO:0043565 | sequence-specific DNA binding |
MF | IEA | GO:0046872 | metal ion binding |
Gene expression in normal tissue: ZBTB16
Gene-model tissue-cancer distribution: Bubble Plot
Gene-drug pathway distribution
Pathways in ZBTB16
Database | Pathway ID | Pathway Des. |
---|---|---|
reactome | R-HSA-1280218 | Adaptive Immune System |
reactome | R-HSA-168256 | Immune System |
reactome | R-HSA-392499 | Metabolism of proteins |
reactome | R-HSA-597592 | Post-translational protein modification |
reactome | R-HSA-8951664 | Neddylation |
reactome | R-HSA-983168 | Antigen processing: Ubiquitination & Proteasome degradation |
reactome | R-HSA-983169 | Class I MHC mediated antigen processing & presentation |
kegg | hsa05200 | Pathways in cancer - Homo sapiens (human) |
kegg | hsa05202 | Transcriptional misregulation in cancer - Homo sapiens (human) |
kegg | hsa05221 | Acute myeloid leukemia - Homo sapiens (human) |
wikipathways | WP2858 | Ectoderm Differentiation |
wikipathways | WP3658 | Wnt-beta-catenin Signaling Pathway in Leukemia |
wikipathways | WP3893 | Development and heterogeneity of the ILC family |
Gene-Drug: Aster Plot
Drug ID | Drug Name | Model Num. |
---|---|---|
iGMDRD269 | Purmorphamine | 2 |
iGMDRD506 | Fedratinib | 3 |
iGMDRD872 | BRD7137 | 3 |
iGMDRD887 | Compound 23 citrate | 3 |
iGMDRD188 | Piperlongumine | 3 |
iGMDRD64 | Parbendazole | 2 |
iGMDRD300 | Tozasertib | 2 |
iGMDRD5 | Tyrphostin AG 1478 | 2 |
iGMDRD202 | Curcumin | 3 |
iGMDRD138 | PX 12 | 2 |
iGMDRD870 | BRD63610 | 1 |
iGMDRD187 | BRD9876 | 1 |
iGMDRD434 | BMS-536924 | 3 |
iGMDRD289 | Parthenolide | 2 |
iGMDRD193 | Fqi1 | 2 |
iGMDRD61 | Kinetin riboside | 1 |
iGMDRD57 | Chloropentafluorobenzene | 4 |
iGMDRD446 | LY 2183240 | 2 |
iGMDRD154 | NSC23766 | 4 |
iGMDRD945 | ML214 | 2 |
iGMDRD394 | BX-795 | 1 |
iGMDRD123 | Isoevodiamine | 3 |
iGMDRD579 | PF750 | 2 |
iGMDRD772 | BRD4770 | 2 |
iGMDRD151 | CHM-1 | 2 |
iGMDRD84 | Lovastatin acid | 2 |
iGMDRD126 | Tipifarnib | 2 |
iGMDRD781 | Sirolimus | 3 |
iGMDRD424 | Tamatinib | 3 |
iGMDRD70 | LHRH analogues or antagonist | 1 |
Gene in drug-gene network: Network Plot
Gene-drug targets distribution
Gene Structure: PDB
Models in ZBTB16